DBV Technologies (DBVT) Receivables Refunds (2015 - 2020)
DBV Technologies (DBVT) reported Receivables Refunds of -$3304.4 for Q2 2020, up 63.24% year-over-year from -$2024.2 in Q3 2019, and up 95.99% on a QoQ basis from -$82342.0 in Q3 2019.
DBV Technologies (DBVT) has 6 years of Receivables Refunds data on file, last reported at -$3304.4 in Q2 2020.
- Quarterly Receivables Refunds rose 63.24% year-over-year to -$3304.4 in Q2 2020, while the trailing twelve-month figure through Jun 2020 was -$3304.4 (up 63.24% YoY) and the FY2018 annual result came in at $4.9 million, down 20.87% from the prior year.
- Receivables Refunds climbed to -$3304.4 in Q2 2020 per DBVT's latest filing, from -$82342.0 in the prior quarter.
- Across five years, Receivables Refunds topped out at $6.2 million in Q4 2017 and bottomed at -$564937.5 in Q2 2016.
- The 5-year median for Receivables Refunds is -$3304.4 (2020), against an average of $1.5 million.
- The widest annual swing landed in 2017, when Receivables Refunds jumped 99.81%; it then slipped 20.87% in 2018.
- Tracing DBVT's Receivables Refunds over 5 years: stood at -$564937.5 in 2016, then soared by 1195.86% to $6.2 million in 2017, then slipped by 20.87% to $4.9 million in 2018, then plunged by 101.68% to -$82342.0 in 2019, then surged by 95.99% to -$3304.4 in 2020.
- Per Business Quant, the three latest DBVT Receivables Refunds figures stand at -$3304.4 (Q2 2020), -$82342.0 (Q3 2019), and -$8989.1 (Q2 2019).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Refund Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | DBV Technologies | 8.00 Bn | 7.77 Bn | -3.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | -3,304.38 |
| Sep 30, 2019 | -82,342.02 |
| Jun 30, 2019 | -8,989.11 |
| Dec 31, 2018 | 4.90 Mn |
| Dec 31, 2017 | 6.19 Mn |
| Jun 30, 2017 | -1,099.55 |
| Jun 30, 2016 | -564,937.51 |
| Dec 31, 2015 | 2.80 Mn |